Literature DB >> 29054896

Metastatic melanoma of unknown primary in the temporalis muscle.

Marco Dalle Carbonare1, Mei Xien Goh1, Zainab AlshiekhAli2, David Howlett3.   

Abstract

Melanomas are aggressive cancers that present as cutaneous, mucosal and ocular lesions with the ability to metastasise widely. There are, however, occasions where lesions are found in distant sites such as lymph nodes, viscera and subcutaneous tissues without clinically apparent skin involvement. This is known as metastatic melanoma of unknown primary (MUP). Its presentation in skeletal muscle is rare, and the available literature is sparse. This article presents an 85-year-old woman with a MUP presenting in the right temporalis muscle, which was diagnosed with the aid of the ultrasound-guided core biopsy. The melanoma deposit was successfully excised, and no recurrence was identified. The patient is now under close follow-up. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  head and neck surgery; radiology; surgical oncology

Mesh:

Year:  2017        PMID: 29054896      PMCID: PMC5665278          DOI: 10.1136/bcr-2017-221577

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  MALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN.

Authors:  T DASGUPTA; L BOWDEN; J W BERG
Journal:  Surg Gynecol Obstet       Date:  1963-09

Review 2.  Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.

Authors:  Kyung Won Kim; Katherine M Krajewski; Jyothi P Jagannathan; Mizuki Nishino; Atul B Shinagare; Jason L Hornick; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 3.  Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature.

Authors:  K Kamposioras; G Pentheroudakis; D Pectasides; N Pavlidis
Journal:  Crit Rev Oncol Hematol       Date:  2010-05-31       Impact factor: 6.312

Review 4.  A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions.

Authors:  Robert L Schmidt; Brian J Hall; Andrew R Wilson; Lester J Layfield
Journal:  Am J Clin Pathol       Date:  2011-07       Impact factor: 2.493

5.  NCCN Clinical Practice Guidelines Occult primary.

Authors:  David S Ettinger; Mark Agulnik; Justin M M Cates; Mihaela Cristea; Crystal S Denlinger; Keith D Eaton; Panagiotis M Fidias; David Gierada; Jon P Gockerman; Charles R Handorf; Renuka Iyer; Renato Lenzi; John Phay; Asif Rashid; Leonard Saltz; Lawrence N Shulman; Jeffrey B Smerage; Gauri R Varadhachary; Jonathan S Zager; Weining Ken Zhen
Journal:  J Natl Compr Canc Netw       Date:  2011-12       Impact factor: 11.908

Review 6.  Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies.

Authors:  Jung Min Bae; Yoon Young Choi; Dae Suk Kim; Ji Hye Lee; Hong Sun Jang; Joo Hee Lee; Heesu Kim; Byung Ho Oh; Mi Ryung Roh; Kyoung Ae Nam; Kee Yang Chung
Journal:  J Am Acad Dermatol       Date:  2014-11-01       Impact factor: 11.527

7.  Unknown Primary Melanoma: Worldwide Survey on Clinical Management.

Authors:  Simone Ribero; Riccardo Pampena; Veronique Bataille; Elvira Moscarella; Luc Thomas; Pietro Quaglino; Concetta Potenza; Alexander C J Van Akkooi; Alessandro Testori; Paul Nathan; Susana Puig; Iris Zalaudek; Giuseppe Argenziano; Caterina Longo
Journal:  Dermatology       Date:  2017-01-05       Impact factor: 5.366

8.  Intramuscular metastatic melanoma with an unknown primary.

Authors:  N S Mercer; V S Devaraj
Journal:  Br J Plast Surg       Date:  1990-05

9.  Improved detection of metastatic melanoma by T2*-weighted imaging.

Authors:  P Gaviani; M E Mullins; T A Braga; E T Hedley-Whyte; E F Halpern; P S Schaefer; J W Henson
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

10.  Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors.

Authors:  Faruk Tas
Journal:  J Oncol       Date:  2012-06-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.